Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation
about
CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structureMonomeric solution structure of the prototypical 'C' chemokine lymphotactinDimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibitionHeterologous quaternary structure of CXCL12 and its relationship to the CC chemokine familyFunctional inhibition of CCR3-dependent responses by peptides derived from phage libraries.Crystal structure and structural mechanism of a novel anti-human immunodeficiency virus and D-amino acid-containing chemokine.Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV)Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.Structural basis of ligand interaction with atypical chemokine receptor 3.Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.New T-lymphocytic cell lines for studying cell infectability by human immunodeficiency virus.Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role.
P2860
Q27631819-1F4A3BD1-4C13-4E20-AF72-38342B423569Q27635401-DB13E1B1-1FF0-4A7D-B751-1FBFFBC981CDQ27649216-C97907C4-1678-4798-A625-7C0DD214C007Q27658969-B84F1B63-BD1F-4CE9-8057-F4DF0A8DB8A1Q30779108-56DA73ED-87A3-47A7-81E0-A9B753D30F14Q36099267-7BBEBA21-3E6C-4709-B60A-09B54DD22D6FQ36334083-DCDCE055-4871-4BBF-91C6-85E2E5B56084Q37149865-5821D406-D2D6-4EF4-83CF-4D247E8A5971Q37368217-1EE3EA38-7EC4-46DB-BFC5-7C1A17B27557Q37598462-0395CF7A-A543-47C6-8312-E57E3AEE51B4Q37599363-05DE556A-DA5F-4504-A020-072C1BE89195Q38341658-FD87700A-9C29-40F0-8BD6-046380971906Q39412588-216386A7-DE2D-4D98-B5C4-447236533B07Q40781201-4CDF7D72-DE45-47D1-BDBE-CF366BB5F93CQ47897154-E6869914-2F8F-4851-B480-580F2FC27DFA
P2860
Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparison of the structure of ...... mechanism for CCR3 activation
@ast
Comparison of the structure of ...... mechanism for CCR3 activation
@en
Comparison of the structure of ...... mechanism for CCR3 activation
@nl
type
label
Comparison of the structure of ...... mechanism for CCR3 activation
@ast
Comparison of the structure of ...... mechanism for CCR3 activation
@en
Comparison of the structure of ...... mechanism for CCR3 activation
@nl
prefLabel
Comparison of the structure of ...... mechanism for CCR3 activation
@ast
Comparison of the structure of ...... mechanism for CCR3 activation
@en
Comparison of the structure of ...... mechanism for CCR3 activation
@nl
P2093
P356
P1433
P1476
Comparison of the structure of ...... mechanism for CCR3 activation
@en
P2093
D A Thompson
E J Fernandez
S C Peiper
P304
P356
10.1021/BI001166F
P407
P577
2000-10-24T00:00:00Z